Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 326


Introduction to Oncolytic Virotherapy.

Engeland CE, Bell JC.

Methods Mol Biol. 2020;2058:1-6. doi: 10.1007/978-1-4939-9794-7_1.


Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy.

Pelin A, Foloppe J, Petryk J, Singaravelu R, Hussein M, Gossart F, Jennings VA, Stubbert LJ, Foster M, Storbeck C, Postigo A, Scut E, Laight B, Way M, Erbs P, Le Boeuf F, Bell JC.

Mol Ther Oncolytics. 2019 Jul 3;14:246-252. doi: 10.1016/j.omto.2019.06.004. eCollection 2019 Sep 27.


Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion.

Satpathy AT, Granja JM, Yost KE, Qi Y, Meschi F, McDermott GP, Olsen BN, Mumbach MR, Pierce SE, Corces MR, Shah P, Bell JC, Jhutty D, Nemec CM, Wang J, Wang L, Yin Y, Giresi PG, Chang ALS, Zheng GXY, Greenleaf WJ, Chang HY.

Nat Biotechnol. 2019 Aug;37(8):925-936. doi: 10.1038/s41587-019-0206-z. Epub 2019 Aug 2.


Life cycle expression of inbreeding depression in Eucalyptus regnans and inter-generational stability of its mixed mating system.

Griffin AR, Potts BM, Vaillancourt RE, Bell JC.

Ann Bot. 2019 Aug 2;124(1):179-187. doi: 10.1093/aob/mcz059.


An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate In Vivo.

Del Papa J, Petryk J, Bell JC, Parks RJ.

Mol Ther Oncolytics. 2019 May 15;14:107-120. doi: 10.1016/j.omto.2019.05.001. eCollection 2019 Sep 27.


Five-year survival of infants with major congenital anomalies: a registry based study.

Schneuer FJ, Bell JC, Shand AW, Walker K, Badawi N, Nassar N.

Acta Paediatr. 2019 Nov;108(11):2008-2018. doi: 10.1111/apa.14833. Epub 2019 Jun 13.


Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses.

Crupi MJF, Bell JC, Singaravelu R.

Stem Cells. 2019 Jun;37(6):716-723. doi: 10.1002/stem.3004. Epub 2019 Apr 9. Review.


Chromatin-Associated RNA Sequencing (ChAR-seq).

Jukam D, Limouse C, Smith OK, Risca VI, Bell JC, Straight AF.

Curr Protoc Mol Biol. 2019 Apr;126(1):e87. doi: 10.1002/cpmb.87. Epub 2019 Feb 20.


Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer.

Martin NT, Roy DG, Workenhe ST, van den Wollenberg DJM, Hoeben RC, Mossman KL, Bell JC, Bourgeois-Daigneault MC.

Sci Rep. 2019 Feb 12;9(1):1865. doi: 10.1038/s41598-018-38385-7.


Sequential assembly of the septal cell envelope prior to V snapping in Corynebacterium glutamicum.

Zhou X, Rodriguez-Rivera FP, Lim HC, Bell JC, Bernhardt TG, Bertozzi CR, Theriot JA.

Nat Chem Biol. 2019 Mar;15(3):221-231. doi: 10.1038/s41589-018-0206-1. Epub 2019 Jan 21.


The burden of hospitalized sports-related injuries in children: an Australian population-based study, 2005-2013.

Schneuer FJ, Bell JC, Adams SE, Brown J, Finch C, Nassar N.

Inj Epidemiol. 2018 Dec 17;5(1):45. doi: 10.1186/s40621-018-0175-6.


Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials.

Pol JG, Acuna SA, Yadollahi B, Tang N, Stephenson KB, Atherton MJ, Hanwell D, El-Warrak A, Goldstein A, Moloo B, Turner PV, Lopez R, LaFrance S, Evelegh C, Denisova G, Parsons R, Millar J, Stoll G, Martin CG, Pomoransky J, Breitbach CJ, Bramson JL, Bell JC, Wan Y, Stojdl DF, Lichty BD, McCart JA.

Oncoimmunology. 2018 Sep 19;8(1):e1512329. doi: 10.1080/2162402X.2018.1512329. eCollection 2019.


Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors.

Pol JG, Lévesque S, Workenhe ST, Gujar S, Le Boeuf F, Clements DR, Fahrner JE, Fend L, Bell JC, Mossman KL, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2018 Aug 27;7(12):e1503032. doi: 10.1080/2162402X.2018.1503032. eCollection 2018. Review.


Development and applications of oncolytic Maraba virus vaccines.

Pol JG, Atherton MJ, Bridle BW, Stephenson KB, Le Boeuf F, Hummel JL, Martin CG, Pomoransky J, Breitbach CJ, Diallo JS, Stojdl DF, Bell JC, Wan Y, Lichty BD.

Oncolytic Virother. 2018 Nov 26;7:117-128. doi: 10.2147/OV.S154494. eCollection 2018. Review.


Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity.

Walsh SR, Bastin D, Chen L, Nguyen A, Storbeck CJ, Lefebvre C, Stojdl D, Bramson JL, Bell JC, Wan Y.

J Clin Invest. 2019 Feb 1;129(2):518-530. doi: 10.1172/JCI121004. Epub 2018 Dec 18.


Preliminary Impact of the weCare Social Media Intervention to Support Health for Young Men Who Have Sex with Men and Transgender Women with HIV.

Tanner AE, Song EY, Mann-Jackson L, Alonzo J, Schafer K, Ware S, Garcia JM, Arellano Hall E, Bell JC, Van Dam CN, Rhodes SD.

AIDS Patient Care STDS. 2018 Nov;32(11):450-458. doi: 10.1089/apc.2018.0060.


Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.

Hsu J, Hodgins JJ, Marathe M, Nicolai CJ, Bourgeois-Daigneault MC, Trevino TN, Azimi CS, Scheer AK, Randolph HE, Thompson TW, Zhang L, Iannello A, Mathur N, Jardine KE, Kirn GA, Bell JC, McBurney MW, Raulet DH, Ardolino M.

J Clin Invest. 2018 Oct 1;128(10):4654-4668. doi: 10.1172/JCI99317. Epub 2018 Sep 10.


Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis.

Zakaria C, Sean P, Hoang HD, Leroux LP, Watson M, Workenhe ST, Hearnden J, Pearl D, Truong VT, Robichaud N, Yanagiya A, Tahmasebi S, Jafarnejad SM, Jia JJ, Pelin A, Diallo JS, Le Boeuf F, Bell JC, Mossman KL, Graber TE, Jaramillo M, Sonenberg N, Alain T.

PLoS Pathog. 2018 Aug 23;14(8):e1007264. doi: 10.1371/journal.ppat.1007264. eCollection 2018 Aug.


Use of Precision-Cut Lung Slices as an Ex Vivo Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy.

Rosales Gerpe MC, van Vloten JP, Santry LA, de Jong J, Mould RC, Pelin A, Bell JC, Bridle BW, Wootton SK.

Mol Ther Methods Clin Dev. 2018 Aug 4;10:245-256. doi: 10.1016/j.omtm.2018.07.010. eCollection 2018 Sep 21.


Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference.

Bastin D, Aitken AS, Pelin A, Pikor LA, Crupi MJF, Huh MS, Bourgeois-Daigneault MC, Bell JC, Ilkow CS.

J Immunother Cancer. 2018 Jun 19;6(1):62. doi: 10.1186/s40425-018-0366-2.


Transforming the prostatic tumor microenvironment with oncolytic virotherapy.

Atherton MJ, Stephenson KB, Tzelepis F, Bakhshinyan D, Nikota JK, Son HH, Jirovec A, Lefebvre C, Dvorkin-Gheva A, Ashkar AA, Wan Y, Stojdl DF, Belanger EC, Breau RH, Bell JC, Saad F, Singh SK, Diallo JS, Lichty BD.

Oncoimmunology. 2018 Mar 27;7(7):e1445459. doi: 10.1080/2162402X.2018.1445459. eCollection 2018.


Gestation at birth, mode of birth, infant feeding and childhood hospitalization with infection.

Bentley JP, Burgner DP, Shand AW, Bell JC, Miller JE, Nassar N.

Acta Obstet Gynecol Scand. 2018 May 16. doi: 10.1111/aogs.13371. [Epub ahead of print]


Publisher Correction: Oncolytic viruses as engineering platforms for combination immunotherapy.

Twumasi-Boateng K, Pettigrew JL, Kwok YYE, Bell JC, Nelson BH.

Nat Rev Cancer. 2018 Aug;18(8):526. doi: 10.1038/s41568-018-0019-2.


Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones.

Martin NT, Bell JC.

Mol Ther. 2018 Jun 6;26(6):1414-1422. doi: 10.1016/j.ymthe.2018.04.001. Epub 2018 Apr 5. Review.


Oncolytic viruses as engineering platforms for combination immunotherapy.

Twumasi-Boateng K, Pettigrew JL, Kwok YYE, Bell JC, Nelson BH.

Nat Rev Cancer. 2018 Jul;18(7):419-432. doi: 10.1038/s41568-018-0009-4. Review. Erratum in: Nat Rev Cancer. 2018 May 4;:.


Chromatin-associated RNA sequencing (ChAR-seq) maps genome-wide RNA-to-DNA contacts.

Bell JC, Jukam D, Teran NA, Risca VI, Smith OK, Johnson WL, Skotheim JM, Greenleaf WJ, Straight AF.

Elife. 2018 Apr 12;7. pii: e27024. doi: 10.7554/eLife.27024.


Measurement of Mesoscale Conformational Dynamics of Freely Diffusing Molecules with Tracking FCS.

Limouse C, Bell JC, Fuller CJ, Straight AF, Mabuchi H.

Biophys J. 2018 Apr 10;114(7):1539-1550. doi: 10.1016/j.bpj.2018.01.044.


Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey.

Bell JC, Schneuer FJ, Harrison C, Trevena L, Hiscock H, Elshaug AG, Nassar N.

Arch Dis Child. 2018 Jul;103(7):660-664. doi: 10.1136/archdischild-2017-314161. Epub 2018 Feb 22.


Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.

Delaunay T, Violland M, Boisgerault N, Dutoit S, Vignard V, Münz C, Gannage M, Dréno B, Vaivode K, Pjanova D, Labarrière N, Wang Y, Chiocca EA, Boeuf FL, Bell JC, Erbs P, Tangy F, Grégoire M, Fonteneau JF.

Oncoimmunology. 2017 Dec 26;7(3):e1407897. doi: 10.1080/2162402X.2017.1407897. eCollection 2018.


Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.

Selman M, Ou P, Rousso C, Bergeron A, Krishnan R, Pikor L, Chen A, Keller BA, Ilkow C, Bell JC, Diallo JS.

Sci Transl Med. 2018 Jan 24;10(425). pii: eaao1613. doi: 10.1126/scitranslmed.aao1613.


Accidental pharmacological poisonings in young children: population-based study in three settings.

Bell JC, Bentley JP, Downie C, Cairns R, Buckley NA, Katelaris A, Pearson SA, Nassar N.

Clin Toxicol (Phila). 2018 Aug;56(8):782-789. doi: 10.1080/15563650.2017.1422509. Epub 2018 Jan 15.


Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.

Bourgeois-Daigneault MC, Roy DG, Aitken AS, El Sayes N, Martin NT, Varette O, Falls T, St-Germain LE, Pelin A, Lichty BD, Stojdl DF, Ungerechts G, Diallo JS, Bell JC.

Sci Transl Med. 2018 Jan 3;10(422). pii: eaao1641. doi: 10.1126/scitranslmed.aao1641.


Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice.

Aitken AS, Roy DG, Martin NT, Sad S, Bell JC, Bourgeois-Daigneault MC.

J Immunother. 2018 Apr;41(3):125-129. doi: 10.1097/CJI.0000000000000208.


Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple Mechanisms.

Kim M, Nitschké M, Sennino B, Murer P, Schriver BJ, Bell A, Subramanian A, McDonald CE, Wang J, Cha H, Bourgeois-Daigneault MC, Kirn DH, Bell JC, De Silva N, Breitbach CJ, McDonald DM.

Cancer Res. 2018 Feb 15;78(4):922-937. doi: 10.1158/0008-5472.CAN-15-3308. Epub 2017 Dec 19.


Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.

Selman M, Rousso C, Bergeron A, Son HH, Krishnan R, El-Sayes NA, Varette O, Chen A, Le Boeuf F, Tzelepis F, Bell JC, Crans DC, Diallo JS.

Mol Ther. 2018 Jan 3;26(1):56-69. doi: 10.1016/j.ymthe.2017.10.014. Epub 2017 Oct 24.


Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus.

Guo ZS, Liu Z, Sathaiah M, Wang J, Ravindranathan R, Kim E, Huang S, Kenniston TW, Bell JC, Zeh HJ 3rd, Butterfield LH, Gambotto A, Bartlett DL.

Mol Ther Methods Clin Dev. 2017 Sep 30;7:112-122. doi: 10.1016/j.omtm.2017.09.007. eCollection 2017 Dec 15.


Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models.

Le Boeuf F, Gebremeskel S, McMullen N, He H, Greenshields AL, Hoskin DW, Bell JC, Johnston B, Pan C, Duncan R.

Mol Ther Oncolytics. 2017 Aug 4;6:80-89. doi: 10.1016/j.omto.2017.08.001. eCollection 2017 Sep 15.


Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential.

Tong JG, Valdes YR, Sivapragasam M, Barrett JW, Bell JC, Stojdl D, DiMattia GE, Shepherd TG.

BMC Cancer. 2017 Aug 30;17(1):594. doi: 10.1186/s12885-017-3600-2.


cGAS-STING and Cancer: Dichotomous Roles in Tumor Immunity and Development.

Ng KW, Marshall EA, Bell JC, Lam WL.

Trends Immunol. 2018 Jan;39(1):44-54. doi: 10.1016/ Epub 2017 Aug 19. Review.


A Viro-Immunotherapy Triple Play for the Treatment of Glioblastoma.

Bell JC, Ilkow CS.

Cancer Cell. 2017 Aug 14;32(2):133-134. doi: 10.1016/j.ccell.2017.07.012.


RNA-dependent stabilization of SUV39H1 at constitutive heterochromatin.

Johnson WL, Yewdell WT, Bell JC, McNulty SM, Duda Z, O'Neill RJ, Sullivan BA, Straight AF.

Elife. 2017 Aug 1;6. pii: e25299. doi: 10.7554/eLife.25299.


Tudor Domain Containing Protein 3 Promotes Tumorigenesis and Invasive Capacity of Breast Cancer Cells.

Morettin A, Paris G, Bouzid Y, Baldwin RM, Falls TJ, Bell JC, Côté J.

Sci Rep. 2017 Jul 11;7(1):5153. doi: 10.1038/s41598-017-04955-4.


Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.

Le Boeuf F, Selman M, Son HH, Bergeron A, Chen A, Tsang J, Butterwick D, Arulanandam R, Forbes NE, Tzelepis F, Bell JC, Werier J, Abdelbary H, Diallo JS.

Int J Cancer. 2017 Sep 15;141(6):1257-1264. doi: 10.1002/ijc.30813. Epub 2017 Jun 21.


Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation.

Veinalde R, Grossardt C, Hartmann L, Bourgeois-Daigneault MC, Bell JC, Jäger D, von Kalle C, Ungerechts G, Engeland CE.

Oncoimmunology. 2017 Jan 31;6(4):e1285992. doi: 10.1080/2162402X.2017.1285992. eCollection 2017.


Oncolytic Viruses: The Best is Yet to Come.

Lemay CG, Keller BA, Edge RE, Abei M, Bell JC.

Curr Cancer Drug Targets. 2018;18(2):109-123. doi: 10.2174/1568009617666170206111609. Review.


NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine.

Alkayyal AA, Tai LH, Kennedy MA, de Souza CT, Zhang J, Lefebvre C, Sahi S, Ananth AA, Mahmoud AB, Makrigiannis AP, Cron GO, Macdonald B, Marginean EC, Stojdl DF, Bell JC, Auer RC.

Cancer Immunol Res. 2017 Mar;5(3):211-221. doi: 10.1158/2326-6066.CIR-16-0162. Epub 2017 Feb 3.


Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies.

Evgin L, Ilkow CS, Bourgeois-Daigneault MC, de Souza CT, Stubbert L, Huh MS, Jennings VA, Marguerie M, Acuna SA, Keller BA, Lefebvre C, Falls T, Le Boeuf F, Auer RA, Lambris JD, McCart JA, Stojdl DF, Bell JC.

Mol Ther Oncolytics. 2016 Nov 16;3:16027. eCollection 2016.


Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer.

Wong CM, Nash LA, Del Papa J, Poulin KL, Falls T, Bell JC, Parks RJ.

Cancer Gene Ther. 2016 Oct;23(10):355-364. doi: 10.1038/cgt.2016.41. Epub 2016 Oct 14.


Enhancing Expression of Functional Human Sodium Iodide Symporter and Somatostatin Receptor in Recombinant Oncolytic Vaccinia Virus for In Vivo Imaging of Tumors.

Wang J, Arulanandam R, Wassenaar R, Falls T, Petryk J, Paget J, Garson K, Cemeus C, Vanderhyden BC, Wells RG, Bell JC, Le Boeuf F.

J Nucl Med. 2017 Feb;58(2):221-227. doi: 10.2967/jnumed.116.180463. Epub 2016 Sep 15.


N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells.

Corredor JC, Redding N, Bloté K, Robbins SM, Senger DL, Bell JC, Beaudry P.

Mol Ther Oncolytics. 2016 Mar 16;3:16005. doi: 10.1038/mto.2016.5. eCollection 2016.

Supplemental Content

Support Center